Showing results (21-30 of 725) with videos related to

Sort By:
Pageof 73
Clinical Neuropharmacology|January 1, 1986
CNS pharmacology and clinical therapeutic effects of oxiracetamT M Itil, G N Menon, A Songar, et al.
Diseases of the Nervous System|July 1, 1974
New drug developments in the Netherlands. "Tetracyclic" psychotropic drugsT M Itil, N Polvan, K Dincmen, et al.
Biological Psychiatry|June 1, 1975
Comparative symptomatological and evoked potential studies with d-amphetamine, thioridazine, and placebo in hyperkinetic childrenB Saletu, M Saletu, J Simeon, et al.
Diseases of the Nervous System|September 1, 1975
Clinical and CNS effects of oral and I.V. Thyrotropin-releasing hormone in depressed patientsT M Itil, C D Patterson, N Polvan, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1984
CNS effects of citalopram, a new serotonin inhibitor antidepressant (a quantitative pharmaco-electroencephalography study)T M Itil, G N Menon, M M Bozak, et al.
Psychopharmacology Bulletin|November 6, 1998
The pharmacological effects of ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrineT M Itil, E Eralp, I Ahmed, et al.
The Journal of Family Practice|November 1, 1981
A family data base for the family oriented medical recordD M Shapiro
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1994
Analgesic-antiinflammatory drugs inhibit orbicularis oculi reflexes in humans via a central mode of actionS Ferracuti, M G Leardi, G Cruccu, et al.
The Journal of Nervous and Mental Disease|March 1, 1975
Computerized EEG: predictor of outcome in schizophreniaT M Itil, J Marasa, B Saletu, et al.
British Journal of Clinical Pharmacology|January 1, 1983
A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depressionT M Itil, R K Shrivastava, S Mukherjee, et al.
Pageof 73